The mitochondrial spark. Generates energy in your cells. It's a powerful antioxidant that supports your heart, brain, and gums. Your body makes it, but production drops off sharply after age 30.
Reviewed March 2026
Source: Mortensen 2014 Q-SYMBIO + Littarru 2007 review
A randomised crossover trial in 36 healthy men compared two 100 mg coenzyme Q10 formulations. After four weeks of daily intake, fasting plasma coenzyme Q10 had roughly doubled from baseline for both preparations (p < 0.001), with no difference between formulations (p = 0.74). Plasma concentration was the measure, not a symptom.
Where a trial measured an actual number, we show it next to the claim. It is the average across the trials, never a promise about one person.
About 36 percent lower all-cause mortality, across 33 trials.
Adults with heart failure.
About 0.44 mg per litre lower C-reactive protein, across 64 trials.
Adults with metabolic disorders.
Read at the source. The magnitude sits beside the same trial the claim already cites. It describes what the trials measured, never what any one person will feel.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Vital for cellular energy and heart health.
About 36 percent lower all-cause mortality, across 33 trials.
Adults with heart failure. Confidence interval risk ratio 0.64, 95% CI 0.48 to 0.85.
A second line of research, outside the reason most people take this. It is held apart from the claims above and carries its own research strength.
About 0.44 mg per litre lower C-reactive protein, across 64 trials.
Confidence interval 95% CI 0.09 to 0.79 mg per litre lower.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Inside the fatty layers of cell membranes, the reduced form of CoQ10 hands an electron to vitamin E after vitamin E has neutralized a free radical, returning it to its active form. By regenerating vitamin E this way, CoQ10 helps it keep protecting membrane fats from oxidation.
L-carnitine shuttles long-chain fatty acids into the mitochondria to be broken down for energy, and CoQ10 then carries the electrons that process releases through the electron transport chain. Acting at consecutive steps of the same energy-production line, the two support the body's normal ATP production in complementary ways.
Ascorbate reduces the tocopheroxyl radical and takes part in the same redox relay that cycles ubiquinone back to ubiquinol. These sit in one chain that hands electrons along rather than acting in isolation.
PQQ is associated with PGC-1alpha signalling and the making of new mitochondria, while CoQ10 is the electron carrier those mitochondria need in their inner membrane. More mitochondria without more carrier is an incomplete pairing.
Lipoic acid is the cofactor for pyruvate and alpha-ketoglutarate dehydrogenase, feeding NADH into the chain where coenzyme Q accepts electrons, and its dihydro form regenerates other antioxidants. Substrate entry and electron carriage line up.
FAD and FMN made from riboflavin sit in complex I and complex II, which hand their electrons directly to coenzyme Q. Low riboflavin limits the flow into the pool a CoQ10 dose enlarges.
Niacin builds the NAD pool whose reducing equivalents enter the chain at complex I and pass to coenzyme Q. The carrier only moves what the dinucleotide pool delivers.
NR raises intracellular NAD+, the substrate whose reduced form feeds electrons into the respiratory chain that coenzyme Q then carries. Pairing them addresses supply and transport in the same organelle.
Thioredoxin reductase, a selenoprotein, reduces ubiquinone to the active ubiquinol form, so selenium status governs how much of a CoQ10 dose ends up in its antioxidant state. The dependency runs in one clear direction.
ATP is functional as a magnesium complex, and ATP synthase along with many matrix dehydrogenases require magnesium. CoQ10 moves the electrons; magnesium is needed for the energy those electrons pay for to be usable.
Ribose supplies the sugar backbone for rebuilding adenine nucleotides, while CoQ10 supports the chain that phosphorylates them. One restores the pool, the other charges it.
Monacolin K inhibits HMG-CoA reductase, and the same mevalonate pathway supplies the polyprenyl tail of coenzyme Q10. Pairing them replaces what the shared upstream step gives up.
Menaquinone side chains and the CoQ10 isoprenoid tail are both built from prenyl units coming out of the mevalonate pathway. Anything that limits that pathway limits both quinones together.
CoQ10 is crystalline and poorly soluble, and its uptake depends on dissolution into a lipid vehicle and mixed micelles. An oil-based softgel gives a substantially higher plasma response than a dry powder.
Piperine slows intestinal and hepatic metabolism of several lipophilic actives and is associated with higher plasma CoQ10 over sustained dosing. It is included for uptake rather than for any activity of its own.
Endogenous CoQ10 is built from two halves, a polyprenyl tail from the mevalonate pathway and a benzoquinone ring derived from tyrosine by way of 4-hydroxybenzoate. That makes tyrosine a structural precursor rather than an accessory nutrient. Supplying CoQ10 directly bypasses the pathway, so this row explains biosynthesis rather than predicting an additive effect from taking both.
Three of the terminal reactions that finish the ubiquinone head group are methyl transfers that use S-adenosylmethionine as the methyl donor. Methyl group availability is therefore part of endogenous CoQ10 synthesis. This is settled pathway biochemistry and not a claim that taking SAM-e raises anyone's CoQ10 level.
Betaine donates a methyl group to homocysteine via betaine-homocysteine methyltransferase, regenerating methionine and therefore the S-adenosylmethionine pool that the ubiquinone methylation steps draw on. The link to CoQ10 is one step removed, through the shared methyl economy. No trial has measured CoQ10 status after betaine.
5-methyltetrahydrofolate supplies the methyl group for methionine synthase, which regenerates methionine and downstream S-adenosylmethionine. Since the final ubiquinone methylations are SAM-dependent, folate status sits upstream of endogenous CoQ10 assembly. The pathway link is established; an effect of folate on measured CoQ10 has not been demonstrated.
Pyridoxal 5-phosphate is the cofactor for the transamination of tyrosine to 4-hydroxyphenylpyruvate, the step that begins the route toward the 4-hydroxybenzoate ring precursor of ubiquinone. B6 status therefore touches the ring half of endogenous synthesis. This describes biosynthesis, not an additive effect of co-supplementation.
The decaprenyl tail of CoQ10 is assembled from isoprene units generated by the mevalonate pathway, which starts from acetyl-CoA. Pantothenic acid is the precursor of coenzyme A and therefore of the acetyl units that feed it. The connection is textbook and upstream; it does not predict that adding B5 changes CoQ10 status.
Ubiquinol is a lipid-phase reductant that can regenerate alpha-tocopherol from the tocopheroxyl radical, and glutathione supports the aqueous side of the same recycling network through ascorbate. The result is a chain of one-electron handoffs across the membrane boundary rather than four independent antioxidants. The chemistry is established in vitro; net effects in a person taking both are not.
Ubiquinone is the electron acceptor for both complex I, which oxidises NADH, and complex II, which oxidises succinate, making it the junction where those two inputs converge. NAD availability and ubiquinone availability are consecutive links in one chain. This is settled mitochondrial biochemistry and says nothing about the effect of oral dosing.
CoQ10 is a large, highly lipophilic quinone with negligible water solubility, and its absorption depends on bile-salt micelle formation and incorporation into chylomicrons. Dosing it in or with a lipid is the standard way to address that. The requirement for a lipid vehicle is established; the specific choice of carrier oil is a formulation decision, not a ranking.
Because crystalline CoQ10 dissolves so poorly, formulators disperse it with phospholipid emulsifiers to keep it in a fine dispersion rather than as undissolved crystals in the gut. Phospholipids also participate in mixed micelle formation. This addresses the solubility bottleneck and is separate from anything CoQ10 does once absorbed.
Astaxanthin spans the membrane bilayer with polar groups at both surfaces, while ubiquinol sits in the hydrophobic core. They quench radicals in different regions of the same membrane. The chemistry supports the pairing; no combination trial in people is cited here.
Resveratrol is studied as a modulator of sirtuin and PGC-1alpha signalling, which governs how many mitochondria a cell builds, whereas CoQ10 is a component those mitochondria require. In principle one changes capacity and the other supplies a part. This is a mechanistic hypothesis at the signalling level, not a tested combination.
Taurine is required for the taurinomethyluridine modification of mitochondrial tRNA, which affects translation of respiratory chain subunits, and CoQ10 is a carrier within that same chain. The two touch mitochondrial function from different angles. Human co-supplementation data is not cited here, so the row is mechanistic only.
Berberine is well characterised as a complex I inhibitor, which is the accepted explanation for its AMPK activation. Since ubiquinone is the electron acceptor immediately downstream of complex I, the two act on adjacent points in the same chain and their directions of effect are not the same. This is a genuine interaction to flag rather than a pairing to encourage, and no combination trial defines the net result.
Creatine buffers ATP in the cytosol through the phosphocreatine system, while CoQ10 works inside the mitochondrion as an electron carrier during oxidative phosphorylation. One stores energy currency and the other helps make it. The overlap is conceptual, and no combination study is cited here.
Nothing specific on file for Coenzyme Q10. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.CoQ10 is the mobile carrier that moves electrons between the parts of the mitochondrial energy chain.
CoQ10 flips between an oxidised and a reduced form; the reduced one can hand electrons to vitamin E and restore it.
The body builds CoQ10 from two parts, a long fatty tail and a ring made from an amino acid, then adds methyl groups to finish it.
CoQ10's tail is built on the same assembly line as cholesterol, so anything that slows that line lowers CoQ10 in the blood too.
CoQ10 is made either by growing microbes that produce it and then extracting it, or by building the molecule chemically. Either way the finished material has to be the same all-trans shape the body uses, and how much of the wrong shape is present is what quality testing checks.
The same molecule is reached more than one way. Which route a given product used is a manufacturing choice, and the finished compound is the same either way.
The microbial route feeds a carbohydrate substrate with a nitrogen source to a selected strain; the chemical route builds the molecule from synthetic intermediates including a solanesol-derived or synthetic polyprenyl chain.
In the fermentation route, bacteria or yeast such as Rhodobacter or Agrobacterium species accumulate CoQ10 intracellularly. In the synthetic route the quinone ring and the decaprenyl chain are coupled chemically.
For fermented material the biomass is separated and disrupted and the lipophilic quinone is recovered with organic solvent.
Crude CoQ10 is purified and crystallised. Both routes are specified to yield the all-trans isomer, which is the isomer found in human tissue; cis isomer content is a quality specification.
Purity and isomer ratio are measured by chromatography, and crystal size is controlled or the material is dispersed, since undissolved crystals limit absorption.
The crystalline powder goes into oil-filled softgels, dry powder capsules and tablets, or solubilised and cyclodextrin-complexed systems.
Labels seldom state the production route, the isomer specification, or whether the CoQ10 is crystalline or dispersed, and the last of these bears directly on how much dissolves.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
These are the studies our verdict leans on, chosen from the 1,584 we read for Coenzyme Q10. The full linked list is below.
12 sources behind our Coenzyme Q10 verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Read this carefully. These are 56,337 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Coenzyme Q10 is, not how risky it is. A report is not proof Coenzyme Q10 caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.
